{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T03:09:38Z","timestamp":1789787378752,"version":"4.0.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jamda.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Medical Directors Association"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.jamda.2023.04.004","type":"journal-article","created":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T15:48:34Z","timestamp":1684597714000},"page":"1290-1296.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Hospitalization and the Risk of Initiation of Antipsychotics in Persons With Parkinson's Disease"],"prefix":"10.1016","volume":"24","author":[{"given":"Aki","family":"Pirttil\u00e4","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miia","family":"Tiihonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Paakinaho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirpa","family":"Hartikainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9270-9268","authenticated-orcid":false,"given":"Anna-Maija","family":"Tolppanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jamda.2023.04.004_bib1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/ene.14108","article-title":"Parkinson disease","volume":"27","author":"Balestrino","year":"2020","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jamda.2023.04.004_bib2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jns.2009.08.014","article-title":"Epidemiology of psychosis in Parkinson\u2019s disease","volume":"289","author":"F\u00e9nelon","year":"2010","journal-title":"J\u00a0Neurol Sci"},{"key":"10.1016\/j.jamda.2023.04.004_bib3","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1750-3639.2009.00369.x","article-title":"The epidemiology of dementia associated with Parkinson\u2019s disease","volume":"20","author":"Aarsland","year":"2010","journal-title":"Brain Pathol"},{"key":"10.1016\/j.jamda.2023.04.004_bib4","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/WNF.0000000000000080","article-title":"Adverse reactions to antipsychotics in Parkinson disease: an analysis of the Spanish pharmacovigilance database","volume":"38","author":"Lertxundi","year":"2015","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.jamda.2023.04.004_bib5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.parkreldis.2022.08.024","article-title":"Incidence of antipsychotic use among community dwellers with and without Parkinson\u2019s disease","volume":"103","author":"Lilja","year":"2022","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.jamda.2023.04.004_bib6","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/mds.27256","article-title":"Prevalence of and indications for antipsychotic use in Parkinson\u2019s disease","volume":"33","author":"Bower","year":"2018","journal-title":"Mov Disord"},{"key":"10.1016\/j.jamda.2023.04.004_bib7","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/mds.21192","article-title":"Antipsychotic use in older adults with Parkinson\u2019s disease","volume":"22","author":"Marras","year":"2007","journal-title":"Mov Disord"},{"key":"10.1016\/j.jamda.2023.04.004_bib8","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1002\/mds.23719","article-title":"Incidence, prescription patterns, and determinants of antipsychotic use in patients with Parkinson\u2019s disease","volume":"26","author":"Wang","year":"2011","journal-title":"Mov Disord"},{"key":"10.1016\/j.jamda.2023.04.004_bib9","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00228-002-0441-x","article-title":"Antipsychotics and Parkinson\u2019s disease: association with disease and drug choice during the first 5 years of antiparkinsonian drug treatment","volume":"58","author":"van de Vijver","year":"2002","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jamda.2023.04.004_bib10","first-page":"95","article-title":"Dementia in Parkinson\u2019s disease","volume":"96","author":"Rippon","year":"2005","journal-title":"Adv Neurol"},{"key":"10.1016\/j.jamda.2023.04.004_bib11","author":"Chokhawala"},{"key":"10.1016\/j.jamda.2023.04.004_bib12","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.cger.2019.09.002","article-title":"Orthostatic hypotension in Parkinson disease","volume":"36","author":"Palma","year":"2020","journal-title":"Clin Geriatr Med"},{"key":"10.1016\/j.jamda.2023.04.004_bib13","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.parkreldis.2011.04.016","article-title":"Prevalence of orthostatic hypotension in Parkinson\u2019s disease: a systematic review and meta-analysis","volume":"17","author":"Velseboer","year":"2011","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.jamda.2023.04.004_bib14","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/mds.26079","article-title":"Orthostatic hypotension in Parkinson disease: how much you fall or how low you go?","volume":"30","author":"Palma","year":"2015","journal-title":"Mov Disord"},{"key":"10.1016\/j.jamda.2023.04.004_bib15","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1212\/WNL.0000000000002670","article-title":"Quality improvement in neurology: Parkinson disease update quality measurement set: executive summary","volume":"86","author":"Factor","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.jamda.2023.04.004_bib17","series-title":"Parkinson's Dis: Current Care Guidelines","year":"2022"},{"key":"10.1016\/j.jamda.2023.04.004_bib18","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1001\/archneurol.2011.139","article-title":"Patterns and trends in antipsychotic prescribing for Parkinson disease psychosis","volume":"68","author":"Weintraub","year":"2011","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jamda.2023.04.004_bib19","first-page":"198","article-title":"Treatment patterns with antipsychotics in long-term care patients with Parkinson\u2019s disease psychosis","volume":"41","author":"Rashid","year":"2022","journal-title":"J\u00a0Appl Gerontol"},{"key":"10.1016\/j.jamda.2023.04.004_bib20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s40801-021-00284-1","article-title":"Falls and fractures in patients with Parkinson\u2019s disease-related psychosis treated with Pimavanserin vs Atypical Antipsychotics: a cohort Study","volume":"9","author":"Layton","year":"2022","journal-title":"Drugs Real World Outcomes"},{"key":"10.1016\/j.jamda.2023.04.004_bib21","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.jamda.2020.12.021","article-title":"Does recent hospitalization increase antipsychotic initiation among community dwellers with Alzheimer\u2019s Disease?","volume":"22","author":"Hakala","year":"2021","journal-title":"J\u00a0Am Med Dir Assoc"},{"key":"10.1016\/j.jamda.2023.04.004_bib22","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1212\/WNL.60.1.87","article-title":"The impact of comorbid disease and injuries on resource use and expenditures in parkinsonism","volume":"60","author":"Pressley","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.jamda.2023.04.004_bib23","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/s12877-021-02145-6","article-title":"Incidence of antidepressant use among community dwellers with and without Parkinson\u2019s disease\u2013a nationwide cohort study","volume":"21","author":"Hentil\u00e4","year":"2021","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.jamda.2023.04.004_bib24","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.parkreldis.2014.04.019","article-title":"Diagnostic accuracy of parkinsonism syndromes by general neurologists","volume":"20","author":"Joutsa","year":"2014","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.jamda.2023.04.004_bib25","doi-asserted-by":"crossref","first-page":"e0198736","DOI":"10.1371\/journal.pone.0198736","article-title":"Identifying Parkinson\u2019s disease and parkinsonism cases using routinely collected healthcare data: a systematic review","volume":"14","author":"Harding","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jamda.2023.04.004_bib26","first-page":"781479","article-title":"Medical record review to differentiate between Idiopathic Parkinson\u2019s Disease and Parkinsonism: a Danish Record Linkage Study with 10 years of follow-up","volume":"2015","author":"Wermuth","year":"2015","journal-title":"Parkinsons Dis"},{"key":"10.1016\/j.jamda.2023.04.004_bib27","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease: a clinico-pathological study of 100 cases","volume":"55","author":"Hughes","year":"1992","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jamda.2023.04.004_bib28","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.3233\/JAD-180593","article-title":"Factors associated with length of stay in hospital patients with and without dementia","volume":"67","author":"M\u00f6llers","year":"2019","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.1016\/j.jamda.2023.04.004_bib29","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/gps.5282","article-title":"New use of psychotropic medication after hospitalization among people with dementia","volume":"35","author":"M\u00f6llers","year":"2020","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.jamda.2023.04.004_bib30","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1017\/S0317167100009665","article-title":"Depression in Parkinson\u2019s disease","volume":"37","author":"Jasinska-Myga","year":"2010","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.jamda.2023.04.004_bib31","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1002\/mds.22589","article-title":"Neuropsychiatric symptoms in Parkinson\u2019s disease","volume":"24","author":"Aarsland","year":"2009","journal-title":"Mov Disord"},{"key":"10.1016\/j.jamda.2023.04.004_bib32","series-title":"Insomnia: Current Care Guidelines","year":"2020"},{"key":"10.1016\/j.jamda.2023.04.004_bib33","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/00002826-198812000-00004","article-title":"The nighttime problems of Parkinson\u2019s disease","volume":"11","author":"Lees","year":"1988","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.jamda.2023.04.004_bib34","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2165\/11315960-000000000-00000","article-title":"Validity of the Finnish Prescription Register for measuring psychotropic drug exposures among elderly finns: a population-based intervention study","volume":"27","author":"Rikala","year":"2010","journal-title":"Drugs Aging"}],"container-title":["Journal of the American Medical Directors Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525861023003948?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525861023003948?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T19:31:12Z","timestamp":1761507072000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525861023003948"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":33,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S1525861023003948"],"URL":"https:\/\/doi.org\/10.1016\/j.jamda.2023.04.004","relation":{},"ISSN":["1525-8610"],"issn-type":[{"value":"1525-8610","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hospitalization and the Risk of Initiation of Antipsychotics in Persons With Parkinson's Disease","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Medical Directors Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jamda.2023.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 AMDA - The Society for Post-Acute and Long-Term Care Medicine.","name":"copyright","label":"Copyright"}]}}